Skye Bioscience (SKYE) Stock Highlights

2.7 | -5.59%

2024-12-21 06:28:17

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. It researches and develops and plans to commercialize cannabinoid derivatives through its own directed research efforts and through several license agreements with the University of Mississippi. The companys lead compound, SBI-100, is initially being developed to treat ocular disease.

Statistics

Range Today

2.66 3.09

Volume Today 484.7K

Range 1 Year

2.25 19.41

Volume 1 Year 43.94M

Range 3 Year

1.44 19.41

Volume 3 Year 46.7M

Range 10 Year

1.44 1937.5

Volume 10 Year 51.1M

Highlights

Market Capitalization 173.23M (small)

Floating Shares 17.44M

Current Price 2.7

Price To Earnings -1.58

Price To Book 2.28

Earnings Per Share -3.78

Payout Ratio 0%

Performance

Latest -5.59%

1 Month -37.64%

3 Months -14.56%

6 Months -70.72%

1 Year -16.92%

3 Years -82.58%

5 Years -94.63%

10 Years -99.86%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.